| Wintrobe's clinical hematology MM Wintrobe Lippincott Williams & Wilkins, 2009 | 1609 | 2009 |
| R2* magnetic resonance imaging of the liver in patients with iron overload JS Hankins, MB McCarville, RB Loeffler, MP Smeltzer, M Onciu, FA Hoffer, ... Blood, The Journal of the American Society of Hematology 113 (20), 4853-4855, 2009 | 495 | 2009 |
| Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study JS Hankins, RE Ware, ZR Rogers, LW Wynn, PA Lane, JP Scott, ... Blood 106 (7), 2269-2275, 2005 | 376 | 2005 |
| Streptococcus pneumoniae Translocates into the Myocardium and Forms Unique Microlesions That Disrupt Cardiac Function AO Brown, B Mann, G Gao, JS Hankins, J Humann, J Giardina, P Faverio, ... PLoS pathogens 10 (9), e1004383, 2014 | 245 | 2014 |
| Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study M Eapen, R Brazauskas, MC Walters, F Bernaudin, K Bo-Subait, ... The Lancet Haematology 6 (11), e585-e596, 2019 | 208 | 2019 |
| The effect of hydroxcarbamide therapy on survival of children with sickle cell disease C Lopes de Castro Lobo, JFC Pinto, EM Nascimento, PG Moura, ... British journal of haematology 161 (6), 852-860, 2013 | 194 | 2013 |
| Parental stress in families of children with a genetic disorder/disability and the resiliency model of family stress, adjustment, and adaptation HR Hall, SL Neely-Barnes, JC Graff, TE Krcek, RJ Roberts, JS Hankins Issues in comprehensive pediatric nursing 35 (1), 24-44, 2012 | 191 | 2012 |
| Patient-centered eHealth interventions for children, adolescents, and adults with sickle cell disease: systematic review SM Badawy, RM Cronin, J Hankins, L Crosby, M DeBaun, AA Thompson, ... Journal of medical Internet research 20 (7), e10940, 2018 | 187 | 2018 |
| Glomerular hyperfiltration and albuminuria in children with sickle cell anemia B Aygun, NA Mortier, MP Smeltzer, JS Hankins, RE Ware Pediatric nephrology 26 (8), 1285-1290, 2011 | 176 | 2011 |
| CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease A Sharma, JJ Boelens, M Cancio, JS Hankins, P Bhad, M Azizy, ... New England Journal of Medicine 389 (9), 820-832, 2023 | 170 | 2023 |
| Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin DA Ngo, B Aygun, I Akinsheye, JS Hankins, I Bhan, HY Luo, ... British journal of haematology 156 (2), 259-264, 2012 | 147 | 2012 |
| Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia B Aygun, NA Mortier, MP Smeltzer, BL Shulkin, JS Hankins, RE Ware American journal of hematology 88 (2), 116-119, 2013 | 136 | 2013 |
| American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation J Kanter, RI Liem, F Bernaudin, J Bolaños-Meade, CD Fitzhugh, ... Blood Advances 5 (18), 3668-3689, 2021 | 133 | 2021 |
| A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy JH Estepp, MP Smeltzer, G Kang, C Li, WC Wang, C Abrams, B Aygun, ... American journal of hematology 92 (12), 1333-1339, 2017 | 121 | 2017 |
| A transition pilot program for adolescents with sickle cell disease JS Hankins, R Osarogiagbon, P Adams-Graves, L McHugh, V Steele, ... Journal of Pediatric Health Care 26 (6), e45-e49, 2012 | 121 | 2012 |
| Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea JS Hankins, KJ Helton, MB McCarville, CS Li, WC Wang, RE Ware Pediatric blood & cancer 50 (2), 293-297, 2008 | 120 | 2008 |
| Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a US survey study RM Cronin, JS Hankins, J Byrd, BM Pernell, A Kassim, P Adams-Graves, ... Hematology 24 (1), 189-198, 2019 | 99 | 2019 |
| “It's our job”: Qualitative study of family responses to ableism SL Neely-Barnes, JC Graff, RJ Roberts, HR Hall, JS Hankins Intellectual and developmental disabilities 48 (4), 245-258, 2010 | 97 | 2010 |
| A program of transition to adult care for sickle cell disease AC Saulsberry, JS Porter, JS Hankins Hematology 2014, the American Society of Hematology Education Program Book …, 2019 | 95 | 2019 |
| Pharmacogenetics for safe codeine use in sickle cell disease RS Gammal, KR Crews, CE Haidar, JM Hoffman, DK Baker, PJ Barker, ... Pediatrics 138 (1), e20153479, 2016 | 95 | 2016 |